Literature DB >> 17786728

Elevated serum BLyS levels in patients with non-Hodgkin lymphoma.

Yasuhiro Oki, Georgios V Georgakis, Thi-Sau Migone, Larry W Kwak, Anas Younes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17786728     DOI： 10.1080/10428190701549562

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  3 in total

1.  B-cell activating factor-receptor specific activation of tumor necrosis factor receptor associated factor 6 and the phosphatidyl inositol 3-kinase pathway in lymphoma B cells.

Authors:  Frank Secreto; Michelle Manske; Tammy Price-Troska; Steven Ziesmer; Lucy S Hodge; Stephen M Ansell; James R Cerhan; Anne J Novak
Journal:  Leuk Lymphoma       Date:  2014-02-24

2.  Genetic variation in B-cell-activating factor is associated with an increased risk of developing B-cell non-Hodgkin lymphoma.

Authors:  Anne J Novak; Susan L Slager; Zachary S Fredericksen; Alice H Wang; Michelle M Manske; Steven Ziesmer; Mark Liebow; William R Macon; Stacey R Dillon; Thomas E Witzig; James R Cerhan; Stephen M Ansell
Journal:  Cancer Res       Date:  2009-04-21       Impact factor: 12.701

3.  Donor-specific Antibodies, Immunoglobulin-free Light Chains, and BAFF Levels in Relation to Risk of Late-onset PTLD in Liver Recipients.

Authors:  Eric A Engels; Linda W Jennings; Matthew J Everly; Ola Landgren; Kazunori Murata; Elizabeth L Yanik; Ruth M Pfeiffer; Nicholas Onaca; Goran B Klintmalm
Journal:  Transplant Direct       Date:  2018-05-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.